Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $22.01 USD
Change Today -0.03 / -0.14%
Volume 323.2K
As of 12:34 PM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Mary Ann Gray Ph.D.

Lead Director, Chairman of Compensation Committee and Member of Nominating & Governance Committee,Dyax Corp.
AgeTotal Calculated CompensationThis person is connected to 47 board members in 4 different organizations across 8 different industries.

See Board Relationships
62$265,215

Background*

Dr. Mary Ann Gray, Ph.D. is the Founder of Gray Strategic Advisors LLC and serves as its President. Dr. Gray has extensive experience in the biotechnology and pharmaceutical industries. She has over twelve years of experience as a scientist in academia and industry. She served as Senior Analyst and Portfolio Manager for Federated Equity Funds - Federated Kaufmann Fund from 1999 to 2003. Dr. Gray spent three and a half years with the Federated Kaufmann Fund focusing on ...

Read Full Background

Corporate Headquarters*

55 Network Drive
Burlington, Massachusetts 01803

United States

Phone: 617-225-2500
Fax: 617-225-2501

Board Members Memberships*

2004-Present
Lead Director, Chairman of Compensation Committee and Member of Nominating & Governance Committee
2005-Present
Independent Director, Chairperson of Audit Committee and Member of Compensation Committee
2010-Present
Director and Member of Compensation Committee
2014-Present
Director and Chairman of Audit Committee

Education*

PhD
The University of Vermont
BS
University of South Carolina

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$60,000
Total Calculated Compensation$265,215
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DYAX:US $22.01 USD -0.03

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Ron Cohen M.D.Founder, Chief Executive Officer, President and Director
Acorda Therapeutics, Inc.
$745.8K
Stanley T. Crooke M.D., Ph.D.Founder, Executive Chairman, Chief Executive Officer, President, Chairman of Science/Medical Committee and Member of Agenda Committee
Isis Pharmaceuticals, Inc.
$1.5M
James A. Schoeneck Chief Executive Officer, President and Director
DepoMed Inc.
$620.1K
George Frederick Wilkinson Chief Executive Officer, President and Director
Impax Laboratories Inc.
$552.5K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DYAX CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.